Contact us

sandra-Challma

Lifestyle Can Prevent Cognitive Decline: Insights from the FINGER Study

Blog /

In an era where dementia and cognitive decline are on the rise, groundbreaking research offers hope. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is a pioneering trial that demonstrates how multidomain lifestyle interventions can significantly improve brain health and prevent cognitive decline. Led by Professor Miia Kivipelto, the study is […]

Lifestyle Can Prevent Cognitive Decline: Insights from the FINGER Study Read More »

Cognes Granted U.S. Patent for AI-Powered Early Dementia Detection Platform

News /

Stockholm, Sweden – June 2024 – Cognes Medical Solutions has been granted a U.S. patent for its AI-powered dementia detection platform, marking a significant step toward revolutionizing early diagnosis and care for neurodegenerative diseases. The patented solution analyzes facial features using machine learning to identify early signs of cognitive decline. Delivered via a smartphone app,

Cognes Granted U.S. Patent for AI-Powered Early Dementia Detection Platform Read More »

Cognes Recognized at Brilliant Minds 2025 for Breakthrough in Early Dementia Detection

News /

Leading the Future of AI-Powered Dementia Detection Cognes wins Brilliant Minds 2025 for its AI-driven dementia screening tool using facial biomarkers. A milestone for innovation in healthtech and longevity. A Global Spotlight on AI and Early Dementia Detection Cognes Medical Solutions, an emerging force in AI-powered healthtech, has been named the Brilliant Minds Innovator of

Cognes Recognized at Brilliant Minds 2025 for Breakthrough in Early Dementia Detection Read More »

Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals

News, Uncategorized /

Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals Cognes Medical Solutions is thrilled to announce its selection as one of the Top 100 companies advancing to the prestigious Entrepreneurship World Cup (EWC) Global Finals. Cognes will join an elite group of startups from 52 countries competing for

Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals Read More »

Alzheimer’s Treatment Assessment: Innovative Strategies for Optimal Results

Blog /

Alzheimer’s disease, a formidable adversary in the realm of neurodegenerative diseases, affects millions worldwide, presenting a significant challenge to both those diagnosed and their loved ones. The quest for effective treatments has long been fraught with the complexities of gauging their true impact. However, a groundbreaking perspective suggesting a major overhaul in how we assess

Alzheimer’s Treatment Assessment: Innovative Strategies for Optimal Results Read More »

Non-Invasive Dementia Care Technology by Cognes Medical Solutions Granted European Patent

Leave a Comment / Uncategorized /

On March 20, 2024, the European Patent Office (EPO) officially granted Cognes Medical Solutions AB a patent for its novel method and system for non-invasive estimation of dementia progression. This novel approach, which utilizes imaging technology to capture and analyze images of a subject’s head from various angles, has the potential to improve early detection

Non-Invasive Dementia Care Technology by Cognes Medical Solutions Granted European Patent Read More »

Assessing Memory Impairment: Alzheimer’s Diagnostics and Treatments of the Future

Blogs /

One of the most significant causes of dementia in the modern world is Alzheimer’s. Yet even though many people are suffering from this terrible disease, there are many challenges in diagnosing Alzheimer’s dementia. Often this is because many of the common symptoms that show up early tend to correspond with other disorders within the neurodegenerative disorder family.

Assessing Memory Impairment: Alzheimer’s Diagnostics and Treatments of the Future Read More »

Scroll to Top